US equities
|
GOOGL
$324.89
▲+0.00%
GOOG
$321.89
▲+0.00%
MU
$983.23
▲+0.00%
SNDK
$1,404.77
▲+0.00%
SKHY
$164.70
▲+0.00%
LITE
$913.95
▲+0.00%
MSFT
$531.01
▲+0.00%
INTC
$95.53
▲+0.00%
GOOGL
$324.89
▲+0.00%
GOOG
$321.89
▲+0.00%
MU
$983.23
▲+0.00%
SNDK
$1,404.77
▲+0.00%
SKHY
$164.70
▲+0.00%
LITE
$913.95
▲+0.00%
MSFT
$531.01
▲+0.00%
INTC
$95.53
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about George Polimenakos
Recent news which mentions George Polimenakos
Tilray's CBD100 Approved For Clinical Trials In Australia And New Zealand By The Natural Health Science Foundation
August 23, 2022
Tickers
TLRY
Tags
Nigel Pollard
Penny Stocks
The Natural Health Science Foundation
From
Benzinga
Tilray Expands Medical Marijuana Product Offering In Australia, Launches Cannabis E-Learning Platform
January 25, 2022
Tickers
TLRY
Tags
Benzinga
Denise Faltischek
Markets
From
Benzinga